Search
Does the patient with myelofibrosis feel better through Pacritinib?
Pacritinib is an oral next-generation multikinase inhibitor with specificity for JAK2 and FLT3 being evaluated to treat myelofibrosis in two Phase 3 trials.
Read moreHematology Jobs
In this section of the EHA website, job opportunities within the field of hematology are posted, when available. Regulations
Service meant for hematologists and related disciplines.
“Complement-ing” positive outcomes during the COVID-19 pandemic
Dr Dimitrios Mastellos (@dmastellos)
The COVID-19 pandemic has had a huge impact on research worldwide. Multiple projects have been halted and researchers have lost their jobs.
EHA supports the European Medicines Agency's investigation into risk based quality management of clinical trials
EHA has responded to the EMA’s call for comments on the reflection paper on February 15.
Read moreScam alert
Beware of unauthorized or fraudulent hotel and registration booking agencies. INTERPLAN AG is the official housing bureau for the EHA2025 Congress.
Read more